Great Lakes Retirement’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,989
Closed -$515K 226
2023
Q3
$515K Buy
4,989
+248
+5% +$27.7K 0.09% 161
2023
Q2
$576K Buy
4,741
+38
+0.8% +$5.07K 0.1% 155
2023
Q1
$722K Buy
+4,703
New +$776K 0.14% 136

Other funds holding MRNA

Great Lakes Retirement's MRNA Position: Q4 2023 in Review

Great Lakes Retirement sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,989 shares — an estimated $515K sold.

Great Lakes Retirement first reported a position in MRNA in Q1 2023 and held it in 3 quarters. The position peaked at $722K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Great Lakes Retirement reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Great Lakes Retirement sold 4,989 Moderna shares in Q4 2023, an estimated $515K.
  • Great Lakes Retirement first reported a position in Moderna in Q1 2023 and held it in 3 quarters.
  • Great Lakes Retirement's Moderna position peaked at $722K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Great Lakes Retirement's 13F filing for Q4 2023, filed 18 Jan 2024.